Alpha Tau Medical Ltd. — Form 6-K Summary
Business context and reporting period
Alpha Tau Medical Ltd., an Israeli foreign private issuer, filed this Form 6-K on March 28, 2022, covering March 2022. The filing reports that the company issued a press release titled “Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update.”
Financial metrics
The filing text provided does not include the attached press release or clear values for revenue, net income or loss, cash flow, margins, debt, liquidity, cash balances, or other financial metrics.
Material changes versus the prior comparable period
The filing text does not provide comparative financial results or describe specific changes from the prior period.
Guidance, outlook, risks, and unusual items
The filing identifies a corporate update and full-year 2021 financial results but does not provide the underlying management commentary, guidance, outlook, risk factors, contingencies, or unusual items. These details were contained or expected to be contained in Exhibit 99.1, which is not included in the supplied text.
Key facts for investors to verify
- Obtain and review Exhibit 99.1, the March 28, 2022 press release.
- Verify full-year 2021 revenue, operating expenses, net loss, cash flow, cash and equivalents, and debt.
- Review management’s corporate update, business milestones, clinical or regulatory developments, and forward-looking guidance.
- Assess liquidity, capital needs, and any risks or contingencies disclosed in the press release.
- Confirm that the filing was signed by Chief Executive Officer Uzi Sofer on March 28, 2022.